About Infinia ML
As Aspirion’s research and development engine, Infinia ML was built to meet those demands—translating AI research into production solutions that drive measurable results across Aspirion’s revenue cycle management operations.
By combining advanced machine learning with Aspirion’s deep revenue cycle expertise and national scale, we deliver AI that drives measurable revenue recovery for hospitals and health systems nationwide.
Infinia ML brings together machine learning researchers and AI engineers with Ph.D. roots and real industry—experience 35+ people and growing, headquartered in Durham, NC, with team members across the country.
Spun out of Duke University’s research labs in 2017 and acquired by Aspirion in 2023, we sit at the intersection of rigorous applied science and one of healthcare’s hardest operational problems: getting providers paid accurately, quickly, and transparently for their work.
That combination is rare. We’ve built a team to match.
